Investigation of Blood Count-Based Inflammatory Biomarkers as Predictors of Response to Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps by Michael Habenbacher, Ulrich Moser, Ahmed Abaira, Peter Kiss, Clemens Holzmeister, Jakob Pock, Katharina Walla, Angelika Lang, Alexandros Andrianakis

Subjects: Get full text

The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP by Nicholas J. Campion, Jonas Brugger, Aldine Tu, Victoria Stanek, Faris F. Brkic, Tina J. Bartosik, David T. Liu, Bruna S. Hoehl, Katharina Gangl, Julia Eckl-Dorna, Sven Schneider

Subjects: Get full text

Secukinumab (Anti‐IL‐17A Therapeutic Antibody) Improves Clinical Outcome for a Mixed Endotype CRS by Mihkel Plaas, Agnieska Brazovskaja, Kai Kisand, Liina Tserel, Pärt Peterson

Subjects: Get full text

Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey by Francesca Anastasi, Francesca Anastasi, Frank Rikki Mauritz Canevari, Frank Rikki Mauritz Canevari, Stefania Gallo, Giulia Gramellini, Enrico Heffler, Enrico Heffler, Ignazio La Mantia, Giulia Monti, Martina Ragusa, Alberto Macchi

Subjects: “…chronic rhinosinusitis with nasal polyps (CRSwNP)…”
Get full text